Adedotun Oladiji, is a
General Acute Care Hospital based in Houston, Texas. Adedotun Oladiji is licensed to practice in Texas (license number 25069) and his current practice location is
9432 Katy Fwy Ste 200, Houston, Texas. He can be reached at his office (for appointments etc.) via phone at
(713) 335-5640.
NPI number for Adedotun Oladiji is 1255751798 and his current mailing address is 9432 Katy Fwy Ste 200, Houston, Texas. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1255751798.
Healthcare Provider's Profile
| Full Name | Adedotun Oladiji |
|---|
| Gender | Male |
|---|
| Speciality | General Acute Care Hospital |
|---|
| Location | 9432 Katy Fwy Ste 200, Houston, Texas |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
|---|
NPI Data:
- NPI Number: 1255751798
- Provider Enumeration Date: 04/23/2014
- Last Update Date: 02/08/2024
Medical Identifiers
Medical identifiers for Adedotun Oladiji such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
|---|
| 1255751798 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
|---|
| 183500000X | Pharmacist | 44229 (Texas) | Secondary |
| 282N00000X | General Acute Care Hospital | 25069 (Texas) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Adedotun Oladiji is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
|---|
Adedotun Oladiji,
9432 Katy Fwy Ste 200,
Houston, TX 77055-6330
Ph: (713) 335-5640 | Adedotun Oladiji,
9432 Katy Fwy Ste 200,
Houston, TX 77055-6330
Ph: (713) 335-5640 |
Reviews and Comments